WallStSmart

Lineage, Inc. Common Stock (LINE)vsUniversal Health Realty Income Trust (UHT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Lineage, Inc. Common Stock generates 5209% more annual revenue ($5.36B vs $100.97M). UHT leads profitability with a 17.7% profit margin vs -2.7%. UHT earns a higher WallStSmart Score of 59/100 (C).

LINE

Avoid

34

out of 100

Grade: F

Growth: 4.0Profit: 3.0Value: 5.0Quality: 3.0
Piotroski: 2/9Altman Z: 0.67

UHT

Buy

59

out of 100

Grade: C

Growth: 4.7Profit: 7.5Value: 7.3Quality: 3.0
Piotroski: 4/9Altman Z: 0.36
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for LINE.

UHTUndervalued (+46.7%)

Margin of Safety

+46.7%

Fair Value

$80.51

Current Price

$41.24

$39.27 discount

UndervaluedFair: $80.51Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LINE1 strengths · Avg: 10.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

UHT2 strengths · Avg: 9.0/10
Operating MarginProfitability
37.8%10/10

Strong operational efficiency at 37.8%

PEG RatioValuation
0.638/10

Growing faster than its price suggests

Areas to Watch

LINE4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.4%4/10

0.4% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Operating MarginProfitability
3.3%3/10

Operating margin of 3.3%

Debt/EquityHealth
1.013/10

Elevated debt levels

UHT4 concerns · Avg: 3.3/10
P/E RatioValuation
31.6x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
0.3%4/10

0.3% revenue growth

Market CapQuality
$561.41M3/10

Smaller company, higher risk/reward

Altman Z-ScoreHealth
0.362/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : LINE

The strongest argument for LINE centers on Price/Book.

Bull Case : UHT

The strongest argument for UHT centers on Operating Margin, PEG Ratio. Profitability is solid with margins at 17.7% and operating margin at 37.8%. PEG of 0.63 suggests the stock is reasonably priced for its growth.

Bear Case : LINE

The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.

Bear Case : UHT

The primary concerns for UHT are P/E Ratio, Revenue Growth, Market Cap. Debt-to-equity of 2.63 is elevated, increasing financial risk.

Key Dynamics to Monitor

LINE profiles as a turnaround stock while UHT is a value play — different risk/reward profiles.

LINE is growing revenue faster at 0.4% — sustainability is the question.

UHT generates stronger free cash flow (12M), providing more financial flexibility.

Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.

Bottom Line

UHT scores higher overall (59/100 vs 34/100), backed by strong 17.7% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Lineage, Inc. Common Stock

REAL ESTATE · REIT - INDUSTRIAL · USA

Lineage, Inc. (Ticker: LINE) is an innovative biotechnology company specializing in regenerative medicine, with a focus on developing state-of-the-art cell therapies for conditions such as ocular diseases, spinal cord injuries, and various cancers. Leveraging its proprietary technologies and strong strategic partnerships, Lineage aims to revolutionize patient care with pioneering therapeutic solutions. The company’s dedication to advancing its diverse product pipeline and accelerating clinical trials positions it as a compelling investment prospect for institutional investors looking to engage at the cutting edge of healthcare advancements.

Visit Website →

Universal Health Realty Income Trust

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human service related facilities including intensive care hospitals, rehabilitation hospitals, subacute care facilities, medical / office buildings, emergency departments independent and child care centers.

Want to dig deeper into these stocks?